am
5:14
All the News in one place from Singapore
More than 50 news sites, more than 1000 pieces of news daily

AstraZeneca To Pay $39B For Alexion — 14% Off Its All-Time High

(December 13 03:20) Forbes.com
At $39 billion, AstraZeneca is low-balling its bid for Alexion -- maker of Soliris, a drug that sells for $678,302 a year
You can find the original article here
Who we are Terms of use News Sites Submit Site